0001127602-16-053377.txt : 20160525 0001127602-16-053377.hdr.sgml : 20160525 20160525152908 ACCESSION NUMBER: 0001127602-16-053377 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160523 FILED AS OF DATE: 20160525 DATE AS OF CHANGE: 20160525 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sheridan William P CENTRAL INDEX KEY: 0001439174 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 161674533 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2016-05-23 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001439174 Sheridan William P 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Senior VP - CMO Emp. Stock Option (Right to Buy) 3.22 2016-05-23 4 A 0 148302 0 A 2017-05-23 2026-05-23 Common Stock 148302 148302 D Retention Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. /s/ Alane P. Barnes, by power of attorney 2016-05-25